Filing Flows

Filing Flows › China Pharma Holdings (CPHI) › Who owns the stock

Who owns China Pharma Holdings (CPHI) stock

9 funds reported China Pharma Holdings (CPHI) shares in their latest 13F filings, worth $148K in all. The largest holder is Citadel Advisors LLC ($83K). Last quarter 6 funds added to their stakes and 1 cut them.

Largest holders of CPHI (13F)Largest holders of CPHI (13F)Citadel Advisors LLC$83KTwo Sigma Securities, LLC$24KStoneX Group$14KRenaissance Technologies LLC$10KJane Street Group, LLC$9KGround Swell Capital, LLC$7KUBS Group AG$2KEFG International AG$26Danske Bank A/S$1

Largest holders (13F)

FundSharesValueChangeQuarter
Citadel Advisors LLC125,445$83Kincrease2026-06-30
Two Sigma Securities, LLC35,666$24Knew2026-06-30
StoneX Group16,304$14Knew2026-09-30
Renaissance Technologies LLC15,045$10Kincrease2026-06-30
Jane Street Group, LLC13,886$9Knew2026-06-30
Ground Swell Capital, LLC10,610$7Knew2026-06-30
UBS Group AG3,109$2Kincrease2026-06-30
EFG International AG40$26unchanged2026-06-30
Danske Bank A/S1$1unchanged2026-06-30

China Pharma Holdings' latest quarter

China Pharma Holdings, Q2 2026: revenue $948K (-8% year over year), operating margin -151.0%, net loss $1.5M, operating cash flow −$33K. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CPHI stock?

By the latest 13F filings: Citadel Advisors LLC ($83K); Two Sigma Securities, LLC ($24K); StoneX Group ($14K); Renaissance Technologies LLC ($10K); Jane Street Group, LLC ($9K).

What is the short interest in CPHI?

198,256 shares were sold short at the 2026-10-15 settlement, 220.5% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.